HeartBeat.bio
HeartBeat.bio is a biotech company transforming cardiac drug discovery by developing a proprietary TechBio platform that integrates human biology, AI-driven insights, and advanced automation. Their key product is the Cardioid technology, which generates self-organizing, beating human heart chamber models from induced pluripotent stem cells, closely mimicking human heart development and physiology. This platform enables precise disease modeling and targeted drug discovery for heart diseases such as cardiomyopathies and myocardial fibrosis. The company offers a scalable, high-throughput 384-well assay system combined with AI-powered data analytics to accelerate and de-risk cardiac drug discovery. HeartBeat.bio collaborates with pharma, biotech, academic, and technology partners to develop breakthrough therapies addressing significant unmet medical needs in heart failure, impacting millions globally.
HeartBeat.bio
HeartBeat.bio is a biotech company transforming cardiac drug discovery by developing a proprietary TechBio platform that integrates human biology, AI-driven insights, and advanced automation. Their key product is the Cardioid technology, which generates self-organizing, beating human heart chamber models from induced pluripotent stem cells, closely mimicking human heart development and physiology. This platform enables precise disease modeling and targeted drug discovery for heart diseases such as cardiomyopathies and myocardial fibrosis. The company offers a scalable, high-throughput 384-well assay system combined with AI-powered data analytics to accelerate and de-risk cardiac drug discovery. HeartBeat.bio collaborates with pharma, biotech, academic, and technology partners to develop breakthrough therapies addressing significant unmet medical needs in heart failure, impacting millions globally.